Corcept Therapeutics | CORT - Market Capitalization


Corcept Therapeutics reported $8.66B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Alaunos Therapeutics USD 7M 2M Mar/2026
ANI Pharmaceuticals USD 1.88B 133M Jun/2026
Ardelyx USD 1.48B 63M Mar/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Bristol-Myers Squibb USD 124.51B 2.96B Oct/2026
Canopy Growth CAD 557.13M 99.33M Mar/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Eli Lilly USD 1.31T 216.84B Oct/2026
J&J USD 607B 46.61B Oct/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Merck USD 370.6B 12.1B Oct/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novartis USD 266.01B 25.42B Oct/2026
Novartis USD 288.26B 25.18B Mar/2026
Pacira USD 1.69B 695M Oct/2026
Pfizer USD 138.44B 15.37B Jun/2026
Supernus Pharmaceuticals USD 2.29B 216M Oct/2026
TG Therapeutics USD 8.41B 3.1B Jun/2026